20The melioidosis bacterium, Burkholderia pseudomallei, is increasingly being recognized as a 21 pathogen in patients with cystic fibrosis (CF). We have recently catalogued genome-wide 22 variation of paired, isogenic B. pseudomallei isolates from seven Australasian CF cases, which 23were collected between four and 55 months apart. Here, we extend this investigation by 24 documenting the transcriptomic changes in B. pseudomallei in five cases. Following growth in 25 an artificial CF sputum medium, four of the five paired isolates exhibited significant differential 26 gene expression (DE) that affected between 32 and 792 genes. The greatest number of DE 27 events was observed between patient CF9 strains, consistent with the hypermutator status of 28 the latter strain, which is deficient in the DNA mismatch repair protein MutS. Two patient 29 isolates harbored duplications that concomitantly increased expression of the β-lactamase gene 30 penA, and a 35kb deletion in another abolished expression of 29 genes. Convergent expression 31 profiles in the chronically-adapted isolates identified two significantly downregulated and 17 32 significantly upregulated loci, including the antibiotic resistance-nodulation-division (RND) efflux 33 pump BpeEF-OprC, the quorum-sensing hhqABCDE operon, and a cyanide-and pyocyanin-34 insensitive cytochrome bd quinol oxidase. These convergent pathoadaptations lead to 35